Movicol and Bradykinesia - a phase IV clinical study of FDA data

Summary:

Bradykinesia is reported as a side effect among people who take Movicol (polyethylene glycol 3350), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Azilect, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Bradykinesia when taking Movicol. It is created by eHealthMe based on reports of 14,199 people who have side effects when taking Movicol from the FDA, and is updated regularly.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

What is Bradykinesia?

Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases) is found to be associated with 428 drugs and 469 conditions by eHealthMe. Check the latest studies of Bradykinesia.

On Jul, 08, 2026

14,199 people reported to have side effects when taking Movicol.
Among them, 86 people (0.61%) have Bradykinesia.

Among these 86 people:

How long have people been on Movicol when they have Bradykinesia? *

What is the gender of people who have Bradykinesia when taking Movicol? *

female: 37.21 %
male: 62.79 %

What is the age of people who have Bradykinesia when taking Movicol? *

What are other drugs people take besides Movicol? *

What are other side effects people have besides Bradykinesia? *

Mobility Decreased (ability to move is reduced): 59 people, 68.60%
On And Off Phenomenon: 46 people, 53.49%
Dyskinesia (abnormality or impairment of voluntary movement): 40 people, 46.51%
Freezing Phenomenon: 34 people, 39.53%
Gait Disturbance: 30 people, 34.88%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 29 people, 33.72%
Hallucinations (sensations that appear real but are created by your mind): 20 people, 23.26%
Hallucination, Visual (seeing things that aren't there): 20 people, 23.26%
Muscle Spasms (muscle contraction): 18 people, 20.93%
Confusional State: 17 people, 19.77%

What are the existing conditions these people have? *

Parkinson's Disease: 79 people, 91.86%
Lower Respiratory Tract Infection: 10 people, 11.63%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 3.49%
Depression: 3 people, 3.49%
Laxative Supportive Care: 3 people, 3.49%
Vitamin B12 Deficiency: 2 people, 2.33%
Type 2 Diabetes: 2 people, 2.33%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 2 people, 2.33%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 2 people, 2.33%
Diarrhea: 2 people, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Movicol and have Bradykinesia?

- Check whether Bradykinesia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Movicol:

Movicol (14,249 reports)

Bradykinesia treatments and more:

Bradykinesia (6,795 reports)

Browse all side effects of Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bradykinesia:

Bradykinesia (428 drugs)

Browse all the conditions that are associated with Bradykinesia:

Bradykinesia (469 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Movicol) and Movicol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.